MCM3AP and metastatic malignant neoplasm in the lymph nodes: As shown in the meta-analysis results in Figure 4 and Table 2, the overexpression of MCM3AP-AS1 was significantly related to TNM stage (OR = 2.28, 95% CI 1.14–4.54, P = 0.019, Figure 4(d)), differentiation grade (OR = 1.82, 95% CI 1.11–2.98, P = 0.018, Figure 4(f)), and lymph node metastasis (OR = 2.97, 95% CI 1.83-4.83, P < 0.001, Figure 4(e)).